This Dutch AI Agent Just Raised $2 Million to Tackle a Global Health Crisis

Jan de Vries · 2026-08-28

Let's talk about a problem that's surprisingly common but rarely gets the spotlight. Hearing loss. It affects an estimated 1.5 billion people worldwide. Yet, nearly 80% of those folks never seek treatment. For those who do, the average wait is more than eight years. That's a massive gap between need and care, and a Dutch startup just got a serious cash infusion to try and close it. Clementine, based in Maastricht, has raised $2 million in Seed funding. The round was led by Amsterdam-based Healthy.Capital, an early-stage HealthTech investor with a solid track record. They're betting that Clementine's unique approach can fundamentally change how people engage with hearing healthcare. ### What Is Clementine, Anyway? Founded in 2024 by CEO Vince van de Weijer, Clementine (or ClementineAI) calls itself the world's first AI hearing activation platform. Think of it as a bridge. It's built specifically for the hearing-care industry, sitting between clinics and the millions of potential patients who are hesitant to take the first step. Their core product isn't just software; it's an AI agent named Matthew. ### Meet Matthew, The 24/7 Hearing Care Agent This is where it gets interesting. Matthew is an AI hearing care agent that engages directly with people who might need help. He's designed to answer questions around the clock without judgment. No waiting lists, no awkward pauses. The goal is to educate users, overcome the emotional and practical barriers that stop people from seeking care, and gently guide them toward the right clinic. For hearing clinics, this is a game-changer. They're often flooded with leads but lack the staff to have meaningful, timely conversations with every single one. Matthew can handle that initial outreach, eliminate a ton of administrative work, and—most importantly—translate those calls into actual booked appointments. As Vince van de Weijer puts it, "Clinics don't need more leads; they need better conversations at the right moment. Matthew ensures no patient inquiry goes unanswered." ### The Strategy Behind the Funding This $2 million seed round isn't coming out of nowhere. Clementine has been building momentum. Just months before this funding, they expanded into North America through a partnership with Zoolstra, a marketing agency that works with hearing clinics across the United States and Canada. That move signaled their ambition to scale beyond Europe. The investor, Healthy.Capital, sees the global potential. Douwe Jippes, their managing partner, highlighted Clementine's "deep domain expertise with a clear AI platform strategy that can scale globally." They're not just funding a tool; they're investing in a new model for patient engagement. So, what's the plan for the cash? Clementine will focus on two main areas: - Deepening their AI capabilities to make Matthew even more effective and empathetic. - Expanding partnerships, not just with hearing clinics, but also with optical retailers and other healthcare organizations to reach people where they already are. The big idea here is pairing AI with behavioral science. It's about creating a judgment-free, always-available starting point for hearing care—a conversation someone can have long before they're ready to walk into a clinic. In a world where access is often the biggest barrier, that's a pretty powerful first step. This funding suggests investors believe that step could lead to a much healthier journey for millions.